InvestorsHub Logo
Followers 0
Posts 718
Boards Moderated 0
Alias Born 12/08/2009

Re: guardiangel post# 21060

Wednesday, 04/23/2014 7:59:31 AM

Wednesday, April 23, 2014 7:59:31 AM

Post# of 30046
What does it mean to be VALID with the FDA?

DR-70 is still "valid" because it's in their database as a device that was once cleared for marketing. DR-70 is not currently cleared for marketing though.

Even if it was still cleared, DR-70 won't be an asset of Radient after the last patent expires in five weeks.

Nobody has been predicting bankruptcy since 2006. In 2006, This company didn't look bad -- they had just received FDA clearance and a year later they acquired Jade as a subbsidiary. I have been predicting bankruptcy since 2009, though, because (a) Jade revolted in 2009 and (b) it was obvious that DR-70, even with its FDA clearance, would never be profitable. It's useful for clinical studies of drugs and other tests, but it is not profitable.

I think this company *would* have filed for bankruptcy in 2010 if Biomedreports hadn't come along. Biomedreports said some wildly optimistic and 100% false things about this company in 2010 and 2011, causing the PPS to soar close to $50 and allowing Radient to do some financing that otherwise would not have been possible.

Today, the PPS is 0.0001 and the company is shut down. I think my bankruptcy prediction was pretty close -- far closer than predictions of mergers and financial success.

The 2011 lenders loaned Radient money in 2011 because Radient told them (and the world) they had $20 million equity as collateral and $10 million sales coming in India and were conducting a collaberative study with the Mayo Clinic and were goign to "monetize" an exciting new subsidiary named NuVax. Today, we know that was all false, but I guess the lenders had no way of knowing the truth in 2011.

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.